466 related articles for article (PubMed ID: 32228044)
1. Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.
Marstrand P; Han L; Day SM; Olivotto I; Ashley EA; Michels M; Pereira AC; Wittekind SG; Helms A; Saberi S; Jacoby D; Ware JS; Colan SD; Semsarian C; Ingles J; Lakdawala NK; Ho CY;
Circulation; 2020 Apr; 141(17):1371-1383. PubMed ID: 32228044
[TBL] [Abstract][Full Text] [Related]
2. Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
Abou Alaiwi S; Roston TM; Marstrand P; Claggett BL; Parikh VN; Helms AS; Ingles J; Lampert R; Lakdawala NK; Michels M; Owens AT; Rossano JW; Saberi S; Abrams DJ; Ashley EA; Semsarian C; Stendahl JC; Ware JS; Miller E; Ryan TD; Russell MW; Day SM; Olivotto I; Vissing CR; Ho CY
Circulation; 2023 Aug; 148(5):394-404. PubMed ID: 37226762
[TBL] [Abstract][Full Text] [Related]
3. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
[TBL] [Abstract][Full Text] [Related]
4. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
6. Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
Rosmini S; Biagini E; O'Mahony C; Bulluck H; Ruozi N; Lopes LR; Guttmann O; Reant P; Quarta CC; Pantazis A; Tome-Esteban M; Mckenna WJ; Rapezzi C; Elliott PM
Heart; 2017 Feb; 103(4):300-306. PubMed ID: 27798053
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
[TBL] [Abstract][Full Text] [Related]
8. Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction.
Yagi N; Seguchi O; Mochizuki H; Kuroda K; Nakajima S; Watanabe T; Yanase M; Tadokoro N; Fukushima S; Fujita T; Fukushima N
ESC Heart Fail; 2021 Dec; 8(6):5513-5522. PubMed ID: 34708560
[TBL] [Abstract][Full Text] [Related]
9. Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the
Akhtar MM; Lorenzini M; Cicerchia M; Ochoa JP; Hey TM; Sabater Molina M; Restrepo-Cordoba MA; Dal Ferro M; Stolfo D; Johnson R; Larrañaga-Moreira JM; Robles-Mezcua A; Rodriguez-Palomares JF; Casas G; Peña-Peña ML; Lopes LR; Gallego-Delgado M; Franaszczyk M; Laucey G; Rangel-Sousa D; Basurte M; Palomino-Doza J; Villacorta E; Bilinska Z; Limeres Freire J; Garcia Pinilla JM; Barriales-Villa R; Fatkin D; Sinagra G; Garcia-Pavia P; Gimeno JR; Mogensen J; Monserrat L; Elliott PM
Circ Heart Fail; 2020 Oct; 13(10):e006832. PubMed ID: 32964742
[TBL] [Abstract][Full Text] [Related]
10. LGE-CMR-derived texture features reflect poor prognosis in hypertrophic cardiomyopathy patients with systolic dysfunction: preliminary results.
Cheng S; Fang M; Cui C; Chen X; Yin G; Prasad SK; Dong D; Tian J; Zhao S
Eur Radiol; 2018 Nov; 28(11):4615-4624. PubMed ID: 29728817
[TBL] [Abstract][Full Text] [Related]
11. Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.
Wasserstrum Y; Larrañaga-Moreira JM; Martinez-Veira C; Itelman E; Lotan D; Sabbag A; Kuperstein R; Peled Y; Freimark D; Barriales-Villa R; Arad M
ESC Heart Fail; 2022 Aug; 9(4):2301-2312. PubMed ID: 35488723
[TBL] [Abstract][Full Text] [Related]
12. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
[TBL] [Abstract][Full Text] [Related]
13. The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance.
Pinamonti B; Merlo M; Nangah R; Korcova R; Di Lenarda A; Barbati G; Sinagra G
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):669-77. PubMed ID: 20216227
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy.
Peteiro J; Bouzas-Mosquera A; Fernandez X; Monserrat L; Pazos P; Estevez-Loureiro R; Castro-Beiras A
J Am Soc Echocardiogr; 2012 Feb; 25(2):182-9. PubMed ID: 22137254
[TBL] [Abstract][Full Text] [Related]
15. Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy.
Essayagh B; Resseguier N; Michel N; Casalta AC; Renard S; Donghi V; Carbone A; Piazzai C; Ambrosi P; Levy F; Martel H; Gérard H; Avierinos JF; N'Guyen K; Habib G
Arch Cardiovasc Dis; 2021 Feb; 114(2):96-104. PubMed ID: 33039326
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
Marston NA; Han L; Olivotto I; Day SM; Ashley EA; Michels M; Pereira AC; Ingles J; Semsarian C; Jacoby D; Colan SD; Rossano JW; Wittekind SG; Ware JS; Saberi S; Helms AS; Ho CY
Eur Heart J; 2021 May; 42(20):1988-1996. PubMed ID: 33769460
[TBL] [Abstract][Full Text] [Related]
17. Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; de Groot NM; van Domburg RT; Ten Cate FJ; Michels M
Clin Cardiol; 2014 Aug; 37(8):493-8. PubMed ID: 25044226
[TBL] [Abstract][Full Text] [Related]
18. Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure.
Akhtar MM; Lorenzini M; Pavlou M; Ochoa JP; O'Mahony C; Restrepo-Cordoba MA; Segura-Rodriguez D; Bermúdez-Jiménez F; Molina P; Cuenca S; Ader F; Larrañaga-Moreira JM; Sabater-Molina M; Garcia-Alvarez MI; Arantzamendi LG; Truszkowska G; Ortiz-Genga M; Ruiz IS; Nielsen SK; Rasmussen TB; Robles Mezcua A; Alvarez-Rubio J; Eiskjaer H; Gautel M; Garcia-Pinilla JM; Ripoll-Vera T; Mogensen J; Limeres Freire J; Rodríguez-Palomares JF; Peña-Peña ML; Rangel-Sousa D; Palomino-Doza J; Arana Achaga X; Bilinska Z; Zamarreño Golvano E; Climent V; Peñalver MN; Barriales-Villa R; Charron P; Yotti R; Zorio E; Jiménez-Jáimez J; Garcia-Pavia P; Elliott PM;
JAMA Cardiol; 2021 Aug; 6(8):891-901. PubMed ID: 33978673
[TBL] [Abstract][Full Text] [Related]
19. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry.
Gimeno JR; Olivotto I; Rodríguez AI; Ho CY; Fernández A; Quiroga A; Espinosa MA; Gómez-González C; Robledo M; Tojal-Sierra L; Day SM; Owens A; Barriales-Villa R; Larrañaga JM; Rodríguez-Palomares J; González-Del-Hoyo M; Piqueras-Flores J; Reza N; Chumakova O; Ashley EA; Parikh V; Wheeler M; Jacoby D; Pereira AC; Saberi S; Helms AS; Villacorta E; Gallego-Delgado M; de Castro D; Domínguez F; Ripoll-Vera T; Zorio-Grima E; Sánchez-Martínez JC; García-Álvarez A; Arbelo E; Mogollón MV; Fuentes-Cañamero ME; Grande E; Peña C; Monserrat L; Lakdawala NK;
ESC Heart Fail; 2022 Aug; 9(4):2189-2198. PubMed ID: 36255281
[TBL] [Abstract][Full Text] [Related]
20. Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy.
Fumagalli C; Zocchi C; Cappelli F; Celata A; Tassetti L; Sasso L; Zampieri M; Argirò A; Marchi A; Targetti M; Berteotti M; Maurizi N; Mori F; Livi P; Baldini K; Tomberli A; Girolami F; Favilli S; Mecacci F; Olivotto I
Eur J Prev Cardiol; 2024 Jan; 31(1):3-10. PubMed ID: 37531614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
